Tempest Therapeutics annual gross margin
2015
2016
2017
Tempest Therapeutics Gross Margin Growth & History (TPST)
Tempest Therapeutics's gross margin was −167.80% for fiscal 2017.
View full Tempest Therapeutics company overviewTempest Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2017 | 2017-12-31 | −167.80% | +559.31 pp |
| 2016 | 2016-12-31 | −727.11% | −15.19 pp |
| 2015 | 2015-12-31 | −711.91% | — |
Tempest Therapeutics quarterly gross margin
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2018 | 2018-09-30 | 20.00% | −28.21 pp |
| Q2 2018 | 2018-06-30 | 33.33% | +259.52 pp |
| Q1 2018 | 2018-03-31 | −67.16% | +259.82 pp |
| Q4 2017 | 2017-12-31 | −136.96% | +947.34 pp |
| Q3 2017 | 2017-09-30 | 48.21% | +739.58 pp |
| Q2 2017 | 2017-06-30 | −226.19% | +326.19 pp |
| Q1 2017 | 2017-03-31 | −326.98% | +378.50 pp |
| Q4 2016 | 2016-12-31 | −1,084.30% | −446.72 pp |
| Q3 2016 | 2016-09-30 | −691.37% | +461.96 pp |
| Q2 2016 | 2016-06-30 | −552.38% | −265.71 pp |
| Q1 2016 | 2016-03-31 | −705.48% | −572.15 pp |
| Q4 2015 | 2015-12-31 | −637.58% | — |
| Q3 2015 | 2015-09-30 | −1,153.33% | — |
| Q2 2015 | 2015-06-30 | −286.67% | — |
| Q1 2015 | 2015-03-31 | −133.33% | — |
Tempest Therapeutics gross margin trends
Between the periods ended 2015-12-31 and 2017-12-31, Tempest Therapeutics's gross margin increased from −711.91% to −167.80%, a change of +544.12 percentage points. The latest reported quarter, Q3 2018, shows 20.00%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tempest Therapeutics source filings ↗